The State University of New York

Danfoss (Tianjin) Ltd.

Tianjin University of Traditional Chinese Medicine

Tao Wang

Iwao Ojima

Peng Liu

Liang Fan

Ying Dong

Xiumei Gao

Yi Zhang

Erwei Liu

Lifeng Han

Jacob Vineberg

Dandan Ge

Yu-Han Teng

Xiaojing Zhou

The disclosure discloses a mounting member including two support rails extending side by side. The two support rails include a first section and a second section in an extension direction thereof. The first section is adapted to carry a device with a first size, and the second section is adapted to carry a device with a second size. Grooves are provided on a top surface of the support rails so as to avoid interference between the bottom surface of the device and the top surface of the support rails. The disclosure also discloses a device assembly including a plurality of devices and the mounting member. The mounting member of the present disclosure allows the plurality of devices to be directly mounted on the two support rails without the need of additional support rails or spacers, thereby reducing the number of parts and improving the integrity and ease of installation of the device assembly.

Mounting member and device assembly

The present disclosure relates to a therapeutic agent of the formula:Z&#x2014;C(&#x2550;O)&#x2014;(CH)-&#x3a6;-S&#x2014;S&#x2014;(CRR')-(CH)-C(&#x2550;O)&#x2014;NH&#x2014;(CH)-NH&#x2014;Y[NH&#x2014;(CH)-X-T-W][NH&#x2014;(CH&#x2014;CH&#x2014;O)(CH)-NH&#x2014;V]&#x2003;&#x2003;Formula I

Therapeutic agent for treating tumors

The present disclosure relates to a dendrimer-based conjugate of the formula V-D-C-D'-(T-F), which is useful for tumor targeting drug delivery. The use of asymmetric dendrimers allow for specific targeting as well as synthetic reproducibility.

Synthesis of novel asymmetric bow-tie PAMAM dendrimer-based conjugates for tumor-targeting drug delivery

Foliamngiferosides having the general formula (I) are disclosed, wherein R is H or &#x2014;OCH. The preparation method of the compounds, pharmaceutical compositions comprising the compounds as the active ingredients, the use of the compounds and the pharmaceutical compositions for inhibiting the activity of &#x3b1;-glucosidase are also disclosed. The foliamangiferosides can be used in preparing drugs for treating diabetes.

Foliamangiferosides, preparation method and use thereof

Growing community of inventors

Tianjin, China

Tao Wang